GLS and breast carcinoma: For example, breast cancer has been well studied in which glutamate overproduction by enhanced glutaminase is released via the system xCT to activate mGluR3 signaling to increase invasiveness, and xCT inhibition with sulfasalazine decreases breast tumor growth.